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such as poor water solubility, lack of speci-
ficity to reach the tumor site, and systemic 
side effects.[2,3] To achieve these benefits, 
several materials with different chemical 
compositions have been used to formu-
late nanomedicines, including inorganic 
nanoparticles (NPs),[4–9] liposomes,[10,11] 
polymeric NPs,[12–15] and hybrid nanocom-
posites.[16–18] However, polymers derived 
from natural and biorenewable sources 
have attracted increased interest for bio-
medical applications, because of their bio-
degradability and biocompatibility, as well 
as their availability in large scale and low 
cost.[19,20] Lignocellulosic materials are an 
example of biorenewable polymers derived 
from wood and plant sources, and are con-
stituted by cellulose, hemicellulose, and 
lignin.[21,22] Unlike cellulose, lignin is still 
an underexploited natural source, despite 
of its availability, mainly due to the com-
plex macromolecular structure, which is 
dependent on its source and extraction 
method. However, transforming raw lignin into NPs of uni-
form size and shape can overcome this problem. Lignin NPs 
(LNPs) with different sizes and shapes have been prepared 
using different approaches, such as antisolvent precipitation, 
interfacial crosslinking, polymerization, solvent exchange and 
sonication.[22] In addition to their application as reinforcing 
The surface modification of nanoparticles (NPs) using different ligands is a 
common strategy to increase NP−cell interactions. Here, dentin phospho-
phoryn-derived peptide (DSS) lignin nanoparticles (LNPs) are prepared and 
characterized, the cellular internalization of the DSS-functionalized LNPs 
(LNPs-DSS) into three different cancer cell lines is evaluated, and their efficacy 
with the widely used iRGD peptide is compared. It is shown that controlled 
extent of carboxylation of lignin improves the stability at physiological condi-
tions of LNPs formed upon solvent exchange. Functionalization with DSS and 
iRGD peptides maintains the spherical morphology and moderate polydis-
persity of LNPs. The LNPs exhibit good cytocompatibility when cultured with 
PC3-MM2, MDA-MB-231, and A549 in the conventional 2D model and in the 
3D cell spheroid morphology. Importantly, the 3D cell models reveal aug-
mented internalization of peptide-functionalized LNPs and improve antiprolif-
erative effects when the LNPs are loaded with a cytotoxic compound. Overall, 
LNPs-DSS show equal or even superior cellular internalization than the LNPs-
iRGD, suggesting that DSS can also be used to enhance the cellular uptake of 
NPs into different types of cells, and release different cargos intracellularly.
DSS Peptide
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/smll.201901427.
1. Introduction
Nanotechnology has been significantly applied for the devel-
opment of nanomedicines for biomedical applications, such 
as cancer therapy.[1] Nanomedicines have the potential to over-
come the limitations of the current chemotherapeutic drugs, 
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agents in nanocomposites, LNPs have been recently employed 
for drug delivery applications.[23–26] Moreover, LNPs present 
functional groups that can be chemically modified, and conse-
quently, increase their application potential.[22,23]
In order to improve the accumulation of the nanomedicines 
at the tumor with increased therapeutic effects, the NPs can 
be modified to respond to certain stimuli (e.g., changes in pH, 
temperature, magnetic field, ultrasound intensity, and light)[27] 
or active-targeting ligands (e.g., antibodies, aptamers, and pep-
tides).[28,29] Tumor homing or cell-penetrating peptides, such as 
RGD-containing peptides, are widely used as ligands to target 
NPs to different tumor tissues and cells.[30–32]
LNPs are considered to be biocompatible in the absence of 
active payloads.[24,25] Due to its environmentally friendly prop-
erties and its large availability in nature, we used lignin as a 
starting material for the development of functionalized LNPs 
for active targeting. In this study, we first characterized the 
lignin polymers recovered from the carboxylation reaction, 
and the optimal LNPs were chosen based on their stability 
at physiological conditions. Thereafter, the LNPs were func-
tionalized with a Asp-Ser-Ser (DSS) polypeptide derived from 
dentin phosphophoryn (DPP), due to its ability to function as 
a cell-penetrating peptide.[33] For that, LNPs were conjugated 
to DSS, using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
and N-hydroxysuccinimide (EDC/NHS) coupling chemistry, in 
order to obtain DSS-functionalized LNPs (LNPs-DSS). In addi-
tion, the cellular uptake of LNPs-DSS into cancer cells was com-
pared to the uptake of iRGD-functionalized LNPs (LNPs-iRGD). 
After physicochemical characterization and cytocompatibility 
evaluation of the prepared LNPs, we compared the cellular 
uptake of peptide-functionalized LNPs, using 2D and 3D cell 
models made of three different cancer cell lines. Additionally, 
a poorly water-soluble cytotoxic compound, benzazulene (BZL, 
1-methyl-8-(propan-2-yl)-4-(trifluoromethyl)-3H-benzo[cd]-
azulen-3-one), was used as a model compound for testing the 
loading into LNPs, as well as the in vitro antiproliferation effect 
of the BZL-loaded LNPs, before and after peptide functionaliza-
tion, against different cancer cell lines.
2. Results and Discussion
2.1. Characterization of the Carboxylated Lignin Polymers
Carboxylated lignin was synthesized in order to increase the 
amount of free carboxyl groups for further conjugation reactions 
with the targeting ligands. For this, the hydroxyl groups on the 
original softwood kraft lignin structure were reacted with succinic 
anhydride, with 4-dimethylaminopyridine (DMAP) as a nucleo-
philic catalyst.[23] To find a balance between the lignin carboxyla-
tion degree and the long-term stability at physiological conditions, 
we tested different ratios of lignin:succinic anhydride for the reac-
tion, as summarized in Table S1 (Supporting Information).
In order to confirm the success of the carboxylation reaction, 
Fourier transform infrared spectroscopy (FTIR) instrument 
with a horizontal attenuated total reflectance (ATR) accessory 
was used to analyze and compare the ATR−FTIR spectra of 
the prepared lignin polymers with the original lignin polymer 
(Figure 1a). All the IR absorption bands and respective type of 
vibration present on the lignin structure are detailed in Table S2 
(Supporting Information). Apart from the typical bands present 
on both original and carboxylated lignin polymers, including the 
alcohol and phenol OH (3500–3100 cm−1), the carbonyl groups 
(1600 cm−1) and the aromatic structure (1427–1512 cm−1), all 
the carboxylated lignin polymers exhibited a stronger adsorp-
tion band at ≈1720 cm−1 than the original lignin.[23,34] Stretching 
vibrations of CO, which derive from the carbonyl situated at 
β-location that is also present in the original lignin polymer, can 
also contribute to this band. However, this band corresponds 
predominantly to the stretching vibrations of CO on the free 
carboxyl groups on the carboxylated lignin structure. Moreover, 
it is possible to observe an increase on adsorption band at 
≈1720 cm−1 according to the degree of carboxylation, suggesting 
that the reaction was successful. Additionally, the resulting car-
boxylated lignin polymers were also characterized using phos-
phorus-31 nuclear magnetic resonance (31P NMR) spectroscopy 
to quantitatively determine the carboxyl groups, as well as the 
aliphatic and phenolic OH groups and hydrogen present on 
the lignin structures (Figure 1b). Before the carboxylation reac-
tion, the amount of COOH groups on the original lignin was 
0.455 mmol g−1. However, the mass ratio of lignin:succinic 
anhydride and the amount of carboxyl groups after the reaction 
do not seem to be linearly correlated. Nevertheless, the amount 
of COOH increased consistently from 0.985 mmol g−1 for the 
ratio 5:1 to 2.280 mmol g−1 for the ratio 1:2. This increase was 
generally accompanied by the decrease on the aliphatic OH 
and total phenolic OH groups, suggesting that the hydroxyl 
groups on the original lignin structure were effectively reacted 
with succinic anhydride.
After the carboxylation reaction, LNPs were prepared with the 
carboxylated polymers, using the lignin:succinic anhydride in a 
ratio 1:2 [LNPs (1:2)], 1:1 [LNPs (1:1)], 2:1 [LNPs (2:1)], 3:1 [LNPs 
(3:1)], 4:1 [LNPs (4:1)], and 5:1 [LNPs (5:1)], by solvent exchange 
method described elsewhere.[23,24,35] The LNPs were formed 
during the dialysis process, where the carboxylated lignin mole-
cules self-assembled into colloidal spheres as tetrahydrofuran 
(THF) was gradually replaced by deionized water. Afterward, 
50 µg mL−1 (Figure 1c), 200 µg mL−1 (Figure 1d), and 500 µg mL−1 
(Figure 1e) of LNPs were incubated in 1 × Dulbecco’s phosphate 
buffer saline (PBS; pH 7.4), mimicking the physiological pH, 
at 37 °C and up to 72 h. This dissolution experiment was done 
to evaluate the long-term stability of the LNPs at physiological 
conditions, and yield the ideal carboxylated lignin polymer to 
prepare the LNPs for further conjugation reactions and in vitro 
experiments. For that, the absorbance (λ = 380 nm) of the sam-
ples’ supernatant withdrawn at each time point was measured by 
UV–vis spectroscopy. The LNPs (1:2) were dissolved immediately 
after incubation (data not shown). For the three concentrations of 
LNPs tested, the LNPs (1:1) experienced a complete dissolution 
after 4 h. Both LNPs (2:1) and LNPs (3:1) showed a concentra-
tion-dependent dissolution overtime. After 48 h, the dissolu-
tion of the LNPs at 50, 200, and 500 µg mL−1 was ≈86.7 ± 4.7%, 
80.3 ± 2.5%, and 76.9 ± 3.9% for the LNPs (2:1), and 41.7 ± 3.1%, 
42.9 ± 2.5%, and 26.5 ± 2.1% for the LNPs (3:1), respectively. 
The same concentration-dependent trend for the dissolution of 
LNPs (4:1) and LNPs (5:1) was observed, but no statistically sig-
nificant differences on the dissolution rate between LNPs (4:1) 
and LNPs (5:1) were detected, particularly for the two highest 
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concentrations of LNPs. After 48 h, at 50, 200, and 500 µg mL−1, 
the dissolution of the LNPs (4:1) was ≈24.1 ± 2.8, 12.9 ± 0.8, 
11.7 ± 0.4%, and 17.7 ± 2.0, 10.7 ± 2.3, and 8.2 ± 0.9% for the 
LNPs (5:1), respectively. Generally, the dissolution of the LNPs 
augmented according to the increase on the amount of carboxyl 
groups on the carboxylated lignin polymers. This dissolution 
behavior can be due to the conversion of carboxylic acids into 
carboxylates, because the sodium and potassium ions present 
in the PBS buffer in a basic environment react with the carbox-
ylic acids. The carboxylic acids, with pKa values typically in the 
range of 3–5 in aqueous media at basic pH, will be ionized and 
converted into cation’s carboxylates, and therefore, enhance their 
water solubility at basic pH.[36] This effect is more pronounced 
when the amount of ions in the buffer is higher, i.e., when the 
concentration of LNPs is lower (50 µg mL−1), and therefore, the 
dissolution seems to be dependent on the LNP concentration in 
PBS buffer. Additionally, after a certain carboxylation degree, the 
dissolution rate appears to reach a constant value, as it can be 
observed for the LNPs (4:1) and LNP (5:1), suggesting that some 
degree of dissolution of LNPs will occur, regardless of the car-
boxylation degree after reaction. Based on these observations, we 
decided to select the LNPs (4:1) to carry out the in vitro studies, 
because the LNPs (4:1) present similar dissolution behavior 
to the LNPs (5:1) and lower dissolution than the other ratios 
(1:1, 2:1, and 3:1).
In summary, the ratio 4:1 of lignin:succinic anhydride was 
the best option, because it presents more than two times higher 
amount of COOH (1.132 mmol g−1) than the original lignin, and 
exhibited a good stability at physiological conditions over 72 h.
2.2. Characterization of the Peptide-Functionalized LNPs
After synthesis and characterization of the carboxylated lignin, 
LNPs (4:1), henceforward simply referred as LNPs, were 
prepared using the same dialysis method previously used. 
Small 2019, 1901427
Figure 1. Characterization of the carboxylated lignin polymers by a) ATR−FTIR spectra and b) quantitative 31P NMR measurements. Evaluation of 
the long-term stability of LNPs prepared with the different carboxylated lignin by evaluating the dissolution rate of the LNPs after incubation of 
c) 50 µg mL−1, d) 200 µg mL−1, and e) 500 µg mL−1 in PBS buffer (pH 7.4) up to 72 h. Results are presented as mean ± s.d. (n = 3).
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Afterward, EDC/NHS coupling chemistry was carried out to 
conjugate the LNPs with equal molar amounts of both iRGD 
and DSS peptides, and consequently, the COOH groups on 
the LNPs were covalently bonded to the NH2 group on the 
peptides. Then, the LNPs were characterized for their average 
particle size (Z-average), polydispersity index (PDI), and 
average zeta (ζ)-potential by dynamic light scattering (DLS) 
and transmission electron microscopy (TEM), and ATR−FTIR 
(Figure 2a–c).
Additionally, the LNPs were loaded with a poorly water-
soluble cytotoxic agent (BZL) as a model compound. BZL 
is an inhibitor of oncogenic Pim kinases that are often over-
expressed in hematopoietic malignancies and in some solid 
tumors, including prostate and colon cancers, stimulating the 
cell survival and resistance against chemotherapy and radia-
tion therapy.[37–39] Therefore, the Pim kinases family presents 
a target for pharmacological inhibition in cancer therapy, in 
which new small molecule inhibitors are being developed, 
such as the BZL.[38,40] Besides prostate cancer, BZL has also 
showed an in vitro inhibitory effect on other cancer cell lines, 
including breast cancer.[23,41] The BZL-loaded LNPs (BZL@
LNPs) were prepared using the same solvent exchange method, 
and subsequently functionalized with iRGD and DSS to yield 
BZL@LNPs-iRGD and BZL@LNPs-DSS, respectively. Then, 
the loading degree (LD) and encapsulation efficiency (EE) of 
BZL into LNPs was determined, and the release profile of BZL 
from LNPs was evaluated (Figure 3a–c).
Regarding the DLS characterization (Figure 2a), the bare 
LNPs presented an average size of 165 ± 7 nm, which increased 
after conjugation with iRGD and DSS to 275 ± 11 and 
304 ± 13 nm, respectively. This difference in the size of the two 
peptide-functionalized LNPs can be ascribed to the length and 
molecular weight of the iRGD and DSS, in which the bigger 
and heavier peptide (DSS) gives a higher size for the LNPs than 
the smaller and lighter peptide (iRGD). After loading, the size 
of the BZL@LNPs slightly increased to 235 ± 12 nm. Moreover, 
the same trend on the average size was naturally observed 
after conjugation with peptides, in which the BZL@LNPs-
iRGD showed 309 ± 7 nm and the BZL@LNPs-DSS exhibited 
342 ± 7 nm. As for the size distribution (Figure 2a), the pre-
pared LNPs and BZL@LNPs before and after functionalization 
exhibited PDI values lower than 0.20, suggesting a moderate 
dispersity of the LNPs. The size distribution and morphology 
of the LNPs was also verified by transmission electron micros-
copy (TEM, Figure 2b), where the particles showed an average 
size and moderate dispersity similar to the values found by 
Small 2019, 1901427
Figure 2. Characterization of bare and BZL-loaded LNPs, before and after functionalization with iRGD and DSS by a) measuring average size, PDI, and 
ζ-potential of the LNPs, b) TEM images of the empty LNPs (scale bars are 200 nm), and c) ATR−FTIR spectra of the bare and functionalized LNPs. 
Error bars represent the mean ± s.d. (n ≥ 3).
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DLS. Furthermore, the LNPs showed symmetric and spherical 
shape, due to the suitable interaction between the lignin and 
water during the process of solvent exchange. Moreover, the 
morphology of the LNPs did not change after conjugation with 
iRGD and DSS.
The stability of the bare and peptide-conjugated LNPs was 
also studied in cell culturing medium, supplemented with 10% 
(v/v) of fetal bovine serum (FBS) (Figure S1, Supporting Infor-
mation). During the first minutes of incubation, the size of the 
bare LNPs increased around 100 nm and then was kept constant 
over time. However, the size of both peptide-functionalized 
LNPs increased ≈70 nm during the first 30 min of incubation, 
but decreased over time. This effect might be due to some pro-
tein adsorption that slowly detach from the LNP surface,[42] and 
consequently, their size decreased to the initial values, indicating 
a good stability of the peptide-decorated LNPs after interaction 
with the serum-containing media. Moreover, we previously 
prepared CPP-functionalized LNPs that were positively charged, 
and their size after incubation with cell culturing media con-
taining 10% FBS increased 200 nm and then kept constant over 
time.[23] Furthermore, the negative surface charge of DSS or 
iRGD-functionalized LNPs might be responsible for less protein 
adsorption, and consequently, superior stability in serum-con-
taining medium compared to the CPP-decorated LNPs.[43]
Regarding the surface charge (Figure 2a), the bare LNPs 
obtained a ζ-potential value of −33.2 ± 6.5 mV, similarly to 
the BZL@LNPs that showed −31.3 ± 3.2 mV. However, the 
ζ-potential of LNPs increased after conjugation with iRGD 
and DSS to −22.9 ± 5.0 and −23.4 ± 5.5 mV, respectively. 
Similarly, the ζ-potential of BZL@LNPs also increased, being 
−21.7 ± 4.2 mV for BZL@LNPs-iRGD and −22.2 ± 3.1 mV for 
BZL@LNPs-DSS. This suggested that the functionalization of 
the LNPs with both peptides occurred effectively, due to the 
decreased amount of COOH groups on the LNPs’ surface and 
the overall charge of the side chains of the peptides. This was 
also confirmed by ATR−FTIR (Figure 2c), where the functional 
groups present on the surface of the particles were deter-
mined, and the spectra of the bare and peptide-functionalized 
LNPs was compared. Here, both LNPs-iRGD and LNPs-DSS 
showed a characteristic band near 1670 cm−1 that corresponds 
mostly to the CO stretching vibrations of the amide bond 
(OCNH). Simultaneously, a slight decrease in the inten-
sity of the band at 1720 cm−1 ascribed to the CO stretching 
vibrations of the unconjugated COOH groups was observed 
when compared to the bare LNPs. Overall, the changes in the 
obtained ζ-potential values for the bare and peptide-decorated 
LNPs along with the ATR−FTIR spectra indicated the success 
of the conjugation reactions.
The LD and EE of BZL into LNPs was determined by 
releasing the cargo after dissolving the LNPs in ethanol and 
analyzing the supernatant by high-performance liquid chro-
matography (HPLC, Figure 3a). The LD of BZL in the LNPs, 
LNPs-iRGD, and LNPs-DSS was 17.1 ± 2.0%, 16.1 ± 1.7%, and 
16.5 ± 1.4%, respectively. Accordingly, the EE did not decrease 
significantly after the reactions, indicating that the cargo was 
not released during the conjugation reaction.
The in vitro release profiles of pure BZL, BZL@LNPs, BZL@
LNPs-iRGD, and BZL@LNPs-DSS, were conducted in two dif-
ferent buffers: Hank’s balanced salt solution (HBSS)–2-(N-
morpholino)ethanesulfonic acid (MES) (HBSS–MES, pH 5.5) 
and HBSS–4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) (HBSS–HEPES, pH 7.4), mimicking the tumor 
microenvironment and the physiological pH, respectively 
(Figure 3b,c). The release medium was supplemented with 10% 
FBS after 4 h to induce sink conditions during the release. The 
release of pure BZL at both pH was very low, being ≈5% after 4 h. 
However, the release profile of the BZL was greatly improved 
when loaded into the LNPs at both pH, compared to the pure 
BZL. After 4 h, the release of BZL from LNPs, LNPs-iRGD and 
LNPs-DSS reached plateaus around 30%, 28%, and 31% at pH 
5.5, and 40%, 38%, and 41% at pH 7.4, respectively. The drug 
was released after 4 h, due to the dissolution of the LNPs in 
the release media containing sodium and potassium ions that 
increase the solubility of the LNPs. After 4 h, 10% FBS was 
added to increase the dissolution of the released drug, as the 
FBS is known to increase the solubility of some hydrophobic 
drugs, such as sorafenib.[44] Therefore, the release profiles of 
BZL from LNPs, LNPs-iRGD and LNPs-DSS at pH 5.5 were 
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Figure 3. Evaluation of the a) loading degree (LD) and encapsulation efficiency (EE) of BZL into LNPs, LNPs-iRGD, and LNPs-DSS, and release profiles 
of pure BZL and BZL-loaded LNPs in b) HBSS–MES (pH 5.5) and c) HBSS–HEPES (pH 7.4), supplemented with 10% (v/v) FBS after 4 h, at 150 rpm 
and 37 °C for 6 h. Errors bars represent the mean ± s.d. (n ≥ 3).
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significantly improved after 6 h, being ≈70%, 67%, and 65%, 
respectively. However, at pH 7.4, the release of BZL increased 
after addition of 10% FBS, but decreased after 6 h, which can 
be due to the precipitation or degradation of BZL. The proposed 
nanosystems showed an enhancement of the dissolution rate of 
BZL that together with the higher stability of the BZL at acidic 
pH as in the tumor microenvironment make them suitable for 
cancer therapy applications.
2.3. Cytocompatibility of LNPs Using 2D and 3D Models
The cytotoxicity of the nanomedicines depends on the cell−
NP interactions that relies on the different NPs’ properties, 
including size, shape, composition, and surface charge.[45,46] 
Therefore, we prepared both 2D cell model and 3D tumor 
cell spheroids to evaluate whether the modifications that were 
carried out on the LNPs affected their in vitro cytocompatibility. 
For that, different concentrations of bare and functionalized 
LNPs up to 500 µg mL−1 were incubated during 24 h using the 
2D model with several human cancer cell lines: prostate cancer 
(PC3-MM2, Figure 4a), mammary carcinoma (MDA-MB-231, 
Figure 4b) and lung carcinoma (A549, Figure 4c), which were 
chosen to evaluate the potential cytotoxic effect of BZL in 
different types of cancer cells. Additionally, the 3D spheroid 
model was prepared using the bioprinting method, to study 
the cytocompatibility of the prepared LNPs up to 100 µg mL−1, 
during 48 h incubation (Figure 4d–f).
Using the 2D cell model (Figure 4a–c), the LNPs before and 
after peptide functionalization showed a very good cytocompat-
ibility after 24 h incubation with PC3-MM2 and MDA-MB-231 
cells (Figure 4a,b), with more than 80% of cell viability. How-
ever, the LNPs presented in general higher toxicity toward A549 
(Figure 4c) compared to the other two cell lines, particularly 
Small 2019, 1901427
Figure 4. Cell viability studies of LNPs using a 2D model of a) PC3-MM2, b) MDA-MB-231, and c) A549 cell lines after incubation with LNPs, LNPs-
iRGD, and LNPs-DSS for 24 h at 37 °C, determined by the CellTiter-Glo luminescence assay, in which all data sets were compared to the positive control 
(cell medium). Cell viability studies of LNPs using 3D tumor spheroids of d) PC3-MM2, e) MDA-MB-231, and f) A549 cell lines after incubation with 
LNPs, LNPs-iRGD, and LNPs-DSS for 48 h at 37 °C, determined by the RealTime-Glo MT Cell Viability Assay in which all data sets were compared to 
the positive control (cell medium). The level of the significant differences was set at probabilities of *p < 0.05, **p < 0.01, and ***p < 0.001. Results 
are presented as mean ± s.d. (n ≥ 3).
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at the highest concentrations. This can be ascribed to the 
higher cellular uptake rate of LNPs into A549 compared to 
the other to cell lines (Figure 5), which can cause more toxi-
city. Additionally, the LNPs-DSS presented a general trend to 
be less cytotoxic than LNPs-iRGD for all the cell lines, being 
statistically significant for incubation with PC3-MM2.
When a 3D tumor spheroid model was used (Figure 4d–f), 
the LNPs before and after peptide functionalization showed a 
very good cytocompatibility, even after a longer incubation time 
of 48 h, with cell viability rates higher than 80% for the con-
centrations tested. However, the bare LNPs showed significant 
toxicity at 100 µg mL−1 for MDA-MB-231 (Figure 4e), and 50 and 
100 µg mL−1 for A549 (Figure 4f) cell lines. This can be due to 
a higher content on carboxyl groups of the bare LNPs compared 
to both peptide-functionalized LNPs that induces more toxicity 
to the cells, resulting in an impaired cell viability.[46,47] Therefore, 
the peptide-decorated LNPs were less toxic than the bare LNPs.
2.4. Cell−LNP Interaction Studies
In addition to the cytocompatibility, the physicochemical prop-
erties of the NPs can also affect the way that NPs interact with 
the cells. Different parameters, such as material composi-
tion, NP size and shape, hydrophobicity and hydrophilicity, 
and surface charge and functionalization can dictate their 
cellular uptake.[48,49] Additionally, the decoration of NPs with 
peptides can be carried out to promote an increased the cel-
lular uptake of NPs into different cells and tissues.[30,31] Here, 
we intended to evaluate both qualitatively and quantitatively 
the cellular interaction/uptake of our LNPs with three different 
cell lines, by confocal microscopy and flow cytometry, respec-
tively (Figures 5 and 6). For that, the LNPs were loaded with 
a highly stable fluorescent dye (DiA, 4-[4-(dihexadecylamino)- 
styryl]-N-methylpyridinium iodide), functionalized with iRGD 
and DSS, and incubated with PC3-MM2, MDA-MB-231, and 
A549 during 3 h.
We started by studying the cellular uptake of the bare and 
peptide-functionalized LNPs using the conventional in vitro 2D 
cell culture model (Figure 5). The confocal microscopy images 
showed clearly an increased interaction of both LNPs-iRGD 
and LNPs-DSS with PC3-MM2 (Figure 5a), MDA-MB-231 
(Figure 5b), and A549 (Figure 5c) cell lines. Then, the extracel-
lular fluorescence was quenched with trypan blue, allowing the 
evaluation of the cellular uptake of the prepared LNPs using 
flow cytometry (Figure 5d–i). For the PC3-MM2, the LNPs-DSS 
showed an internalization rate slightly higher than LNPs-iRGD, 
and both peptide-functionalized LNPs showed a statistically sig-
nificant higher cellular uptake than the bare LNPs (Figure 5d). 
These observations were also demonstrated and confirmed by 
the mean fluorescence intensity (MFI) values obtained during 
this analysis (Figure 5e). For MDA-MB-231 (Figure 5f,g) and 
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Figure 5. In vitro cellular interaction studies using a 2D cell culture model: Confocal fluorescence microscopy images of a) PC3-MM2, b) MDA-MB-
231, and c) A549 cell lines, after incubation with 100 µg mL−1 of bare and peptide-functionalized DiA@LNPs for 3 h at 37 °C. DAPI (blue), DiA (green), 
and CellMask Red (red) were used to stain the nucleus, the LNPs, and the cell membrane, respectively. The merged panels show the association of 
the LNPs with the cell membrane. Scale bars are 50 µm. Quantitative cellular uptake by flow cytometry, after incubation of 100 µg mL−1 of LNPs with 
d) PC3-MM2, f) MDA-MB-231, and h) A549, for 3 h at 37 °C in which the LNPs (green) LNPs-iRGD (yellow), and LNPs-DSS (red) were compared to 
the untreated control (gray). MFI quantification for e) PC3-MM2, g) MDA-MB-231, and i) A549 before and after treatment with the DiA@LNPs. At 
least 10 000 events were collected for each measurement. The error bars represent mean ± s.d. (n = 3). Statistical significance was set at probabilities 
of *p < 0.05, **p < 0.01, and ***p < 0.001, and ns is nonsignificant.
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A549 (Figure 5h,i), the LNPs-DSS showed more internaliza-
tion than LNPs and LNPs-iRGD. However, the LNPs were more 
internalized than the LNPs-iRGD for A549. Some studies have 
reported that the high internalization of negatively charged 
NPs, such as COOH modified NPs, can occur via nonspecific 
binding and clustering of NPs on cationic sites on the plasma 
membrane.[50] Furthermore, Guarnieri et al. showed that the 
cellular uptake by the cells of −COOH-modified silica NPs was 
higher than of the −NH2-modified silica NPs.[51] Therefore, the 
surface characteristics of the bare LNPs can lead to an increased 
cellular uptake by A549 compared to the LNPs-iRGD.
Conventionally, the in vitro cellular uptake of NPs is evaluated 
using a 2D model in a flat cell culturing surface, as discussed 
in section 2.3. However, this model does not represent the 3D 
organization and morphology of their native tissues, and the 
cell−cell interactions are not realistic, leading to a misinterpreta-
tion of the cellular uptake and a superior biological efficacy of 
the NPs comparing to the 3D culturing models.[52] Therefore, 
the cellular interactions/uptake of bare and peptide-functional-
ized LNPs with the different cell lines was also assessed using 
a 3D tumor spheroids of ≈600 µm of diameter (Figure 6), and 
the comparison with the conventional 2D model was evaluated. 
Observing the confocal microscopy images of the tumor sphe-
roids, both peptide-decorated LNPs improved the interaction 
with the three cell lines, compared to the bare LNPs (Figure 6a–c). 
Moreover, the LNPs-DSS interact more than LNPs-iRGD with 
the PC3-MM2 and A549. In order to determine the cellular 
uptake, the tumor spheroids were disassembled after the incu-
bation with the LNPs, and the extracellular fluorescence was 
quenched after incubating the cells with trypan blue before the 
flow cytometry analysis. Regarding the PC3-MM2, the cellular 
uptake of the LNPs-DSS was higher than the LNPs-iRGD and 
bare LNPs, which was statistically significant based on the 
MFI values obtained (Figure 6d,e). For the MDA-MB-231, both 
peptide-functionalized NPs showed an increased cellular inter-
nalization than the LNPs (Figure 6f,g). In the case of the A549, 
the same trend for the cellular internalization of LNPs was 
observed, where the LNPs-DSS showed an enhanced uptake 
compared to the LNPs-iRGD and LNPs (Figure 6h,i).
Comparing the two culturing models, the cellular internali-
zation of the LNPs was expectably higher for the 2D cell model 
than for the 3D tumor spheroids, which was correlated with the 
MFI values obtained, i.e., higher MFI for the 2D-cultured cells. 
This can be due to the effect of sedimentation and diffusion of 
the NPs on the 2D cell culturing plate, as well as the stronger 
and more realistic cell−cell interactions in the 3D cell culturing 
model.[53] Additionally, the peptide-decorated LNPs were gener-
ally taken-up more efficiently by the three cell lines than the 
bare LNPs in both cell culturing models. Furthermore, in some 
cases, the LNPs-DSS showed a superior cellular internalization 
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Figure 6. In vitro cellular interaction studies using a 3D tumor spheroids: Confocal fluorescence microscopy images of a) PC3-MM2, b) MDA-MB-231, 
and c) A549 cell lines, after incubation with 100 µg mL−1 of bare and peptide-functionalized DiA@LNPs for 3 h at 37 °C. DAPI (blue) and DiA (green) 
were used to stain the nucleus and the LNPs, respectively. The merged panels show the association of the LNPs with the tumor spheroid. Scale bars 
are 200 µm. Quantitative cellular uptake by flow cytometry, after incubation of 100 µg mL−1 of LNPs with d) PC3-MM2, f) MDA-MB-231, and h) A549, 
for 3 h at 37 °C in which the LNPs (green) LNPs-iRGD (yellow), and LNPs-DSS (red) were compared to the untreated control (gray). MFI quantification 
for e) PC3-MM2, g) MDA-MB-231, and i) A549 before and after treatment with the DiA@LNPs. At least 5000 events were collected for each measure-
ment. The error bars represent mean ± s.d. (n = 3). Statistical significance was set at probabilities of *p < 0.05, **p < 0.01, and ***p < 0.001, and ns 
is nonsignificant.
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than the LNPs-iRGD. The DSS peptide derived from DPP 
is a repetitive DSS-rich domain that facilitates non-receptor-
mediated endocytosis, acting as a cell penetrating peptide. 
DPP contains a conserved RGD domain in several species, 
but this DSS polypeptide was not mediated through integrin 
receptors.[33] Comparing to the iRGD that binds to the integ-
rins overexpressed in the tumor endothelium and improves 
the tissue penetration in a tumor-specific and neuropilin-1-de-
pendent manner,[54] the DSS peptide can improve the cellular 
uptake; however, neither clathrin nor the caveolae-mediated 
pathways was responsible for its internalization.[33] Moreover, 
the disruption of the intracellular transportation mechanisms 
affected the endocytic process, but the disruption of the micro-
tubules and microfilaments involved in this process did not 
prevent the endocytosis of the DSS peptide.[33] Unlike iRGD 
peptide, the cellular internalization of the DSS peptide is not 
related with the amount of receptor/cellular target for its endo-
cytosis. Therefore, the DSS peptide can also be used to enhance 
the cellular uptake of NPs into different types of cells via 
non-receptor-mediated endocytosis, releasing different cargos 
intracellularly for different therapeutic applications.
2.5. In Vitro Antiproliferative Studies
The dimensionality of the culturing method has been shown 
to affect the cytocompatibility and cellular uptake of the NPs, 
as well as the cellular response to the drug treatment.[55] There-
fore, BZL-loaded LNPs and the free BZL were used to treat the 
cells and evaluate the growth inhibition effect of the BZL in 2D 
(Figure 7) and 3D (Figure 8) cell culturing models. Apart from 
its known role as an inhibitor of Pim kinases overexpressed 
in prostate cancer, BZL has been shown to be a potent cyto-
toxic compound against other cell lines.[23,41] Thus, pure BZL 
and BZL-loaded LNPs were incubated with PC3-MM2, MDA-
MB-231 and A549, representing the prostate, breast and lung 
cancers, respectively.
For the 2D model, LNP suspensions ranging from 5 to 
100 µg mL−1 and similar concentrations of the free poorly 
water-soluble BZL previously dissolved with 3% (v/v) ethanol 
in cell media were incubated with the cells in a flat cell surface 
during 6 (Figure 7a–c) and 24 h (Figure 7d–f). Afterward, the 
inhibitory concentration (IC) values by 50% (IC50), 80% (IC80), 
and 90% (IC90) were determined after plotting a concentration 
response curve by nonlinear regression (Table S3, Supporting 
Information). For PC3-MM2, the BZL@LNPs-DSS reached 
the IC50 after 6 h of incubation, unlike the BZL@LNPs-iRGD 
and BZL@LNPs (Figure 7a). After 24 h, the inhibitory effect 
of all the BZL@LNPs presented similar trends toward PC3-
MM2 (Figure 7d). Regarding MDA-MB-231, the incubation 
of the BZL@LNPs was not enough to observe 50% of growth 
inhibition after 6 h (Figure 7b), but after 24 h, the BZL@
LNPs, BZL@LNPs-iRGD, and BZL@LNPs-DSS reached IC90 
values of 31.9 × 10−6, 35.5 × 10−6, and 31.4 × 10−6 m (Figure 7e). 
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Figure 7. Antiproliferative studies using a 2D cell culture model of a,d) PC3-MM2, b,e) MDA-MB-231, and c,f) A549 cell lines treated with pure BZL 
previously dissolved with 3% ethanol (v/v), and different concentrations of BZL-loaded LNPs, LNPs-iRGD, and LNPs-DSS in complete media, for 
a–c) 6 h and d–f) 24 h at 37 °C. Errors bars represent the mean ± s.d. (n ≥ 3).
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For A549, the same trend on the growth inhibition effect of pure 
BZL and BZL-loaded LNPs before and after peptide functionali-
zation was observed after 6 and 24 h of incubation (Figure 7c,f).
Regarding the 3D tumor spheroids, the BZL@LNPs 
(concentrations ranging from 10 to 100 µg mL−1) and similar 
concentrations of free BZL, previously dissolved with 3% (v/v) 
ethanol, were incubated with spheroids during 6, 24, and 48 h 
(Figure 8), and the IC50, IC80, and IC90 were also determined after 
nonlinear regression and detailed in Table S4 (Supporting Infor-
mation). Although the BZL@LNPs showed similar inhibition 
effect after incubation with PC3-MM2 (Figure 8a,d,g), the peptide-
functionalized LNPs appeared to have an increased antiprolifera-
tive effect after 24 h of incubation. Here, the BZL@LNPs-DSS 
presented lower IC80 values (41.7 × 10−6 m) than BZL@LNPs-
iRGD (44.0 × 10−6 m) and BZL@LNPs (49.3 × 10−6 m). The same 
trend in the inhibitory effect was observed for MDA-MB-231 
(Figure 8b,e,h), where the BZL@LNPs-DSS presented inferior 
IC90 values (44.2 × 10−6 m) than BZL@LNPs-iRGD (47.5 × 10−6 m) 
and BZL@LNPs (51.5 × 10−6 m) after a long-term of exposure to 
the LNPs (48 h). Likewise, the IC90 values of both BZL@LNPs-
DSS (60.1 × 10−6 m) and BZL@LNPs-iRGD (57.7 × 10−6 m) was 
lower than the bare BZL@LNPs (70.2 × 10−6 m) after 48 h of 
incubation with A459 (Figure 8i).
Unlike for 2D cell model, the peptide-functionalized BZL@
LNPs showed lower IC values than the bare BZL@LNPs when 
the 3D tumor spheroids model was used to test the antiprolif-
erative effect of BZL. Moreover, the BZL@LNPs-DSS showed 
a superior efficacy than the BZL@LNPs-iRGD, as for MDA-
MB-231 cell line. As expected, the antiproliferative effect of the 
BZL@LNPs was more pronounced toward the 2D cell model, 
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Figure 8. Antiproliferative studies using 3D tumor spheroids of a,d,g) PC3-MM2, b,e,h) MDA-MB-231 and c,f,i) A549 cell lines treated with pure BZL 
previously dissolved with 3% ethanol (v/v), and different concentrations of BZL-loaded LNPs, LNPs-iRGD, and LNPs-DSS in complete media, for 
a–c) 6 h, d–f) 24 h, and g–i) 48 h at 37 °C. Errors bars represent the mean ± s.d. (n ≥ 3).
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with lower IC50 values for the 2D cell model compared to the 
IC values obtained for the 3D tumor spheroids. This can be 
due to the reduced proliferation rate of the cells in 3D culturing 
models compared to the 2D model, leading to a decreased anti-
proliferative effect of the cytotoxic compounds that act more 
potently on proliferating cells.[56]
In summary, all the BZL@LNPs showed an effective anti-
proliferative effect in all the cancer cell lines tested, without 
using any organic solvent (e.g., ethanol) to solubilize the BZL, 
because the solubility of BZL is improved when loaded into the 
LNPs. Moreover, the DSS-decorated BZL@LNPs exhibited a 
good and sustained antiproliferative effect toward the 3D tumor 
spheroids that are more biologically relevant.
3. Conclusion
In this study, all the LNPs showed low cytotoxicity at 
concentrations up to 500 µg mL−1, using the 2D model, and up 
to 100 µg mL−1 for peptide-functionalized LNPs or 50 µg mL−1 
for bare LNPs, using the 3D tumor spheroids. Additionally, the 
peptide-functionalized LNPs showed higher cellular uptake 
than the bare LNPs, which was more pronounced when a 3D 
cell-culturing model was used. Moreover, the BZL@LNPs 
showed an improved antiproliferative effect after incubation 
with three different cancer cell lines cultured in 2D or 3D cell 
models. Overall, the functionalized LNPs showed interesting 
properties for drug delivery and biomedical applications, 
including biocompatibility and ability to load hydrophobic com-
pounds. The LNPs-DSS also presented similar or increased 
cellular internalization and antiproliferative effect properties 
compared to LNPs-iRGD, suggesting that the DSS can also be 
conjugated to NPs as a targeting moiety to enhance the delivery 
of different cargos inside the cells.
4. Experimental Section
Materials and Cell Culturing: BioPiva softwood kraft lignin was 
acquired from UPM Biochemicals (Finland). Benzazulene (BZL) was 
prepared in-house, as described elsewhere.[37] 6xDSS peptide was 
synthesized as described earlier at the University of Illinois at Chicago 
(USA).[33] The iRGD (CCRGDKGPDC) was purchased from GenicBio. 
4-[4-(Dihexadecylamino)styryl]-N-methylpyridinium iodide (DiA) was 
acquired from Thermo Scientific, USA. Other materials and cell culturing 
procedures are detailed in Supporting Information.
Carboxylation of Lignin: The original lignin material was carboxylated 
in order to increase the amount of carboxylic groups for further 
conjugation reactions, using the reaction chemistry described 
elsewhere.[23] Briefly, 100 mg of BioPiva softwood kraft lignin was reacted 
with succinic anhydride, in the presence of DMAP (20 mg) as catalyst, 
in a final volume of 40 mL of THF at room temperature (RT) for 48 h. 
Here, different mass ratios of lignin:succinic anhydride were reacted 
to synthesize different carboxylated lignin polymers, as summarized in 
Table S1 (Supporting Information).
After the reaction, the mixture was dialyzed against MilliQ-water 
using a dialysis bag (Spectra/Por 1 Standard RC Dry Dialysis Tubing, 
12–14 kDa, Spectrum Labs, USA) during 48 h to remove the unreacted 
reagents, replacing the water periodically. Finally, the carboxylated 
lignin was freeze-dried and characterized with an FTIR instrument 
(Vertex 70, Bruker, USA) using a horizontal ATR accessory (MIRacle, 
PIKE Technologies, USA). The ATR-FTIR spectra were recorded at room 
temperature between 4000−650 cm−1 with a resolution of 4 cm−1 using 
OPUS 5.5 software. Additionally, aliphatic hydroxyl, phenolic hydroxyl, 
and carboxyl groups of original softwood kraft lignin and carboxylated 
lignins were analyzed by quantitative 31P NMR spectroscopy.[57] The 
sample preparation and analysis was carried out as described earlier, 
except that now the sample weight was 25 mg and 15 relaxation time 
was used in the inverse-gated pulse sequence.[58,59]
Preparation of Lignin Nanoparticles: The LNPs were prepared by solvent 
exchange, as described elsewhere.[35] For this, the 1 mg of carboxylated 
lignin was dissolved with 1 mL THF and introduced into a dialysis bag 
(Spectra/Por 1 Standard RC Dry Dialysis Tubing, 12−14 kDa, Spectrum 
Labs, USA). The dialysis water was periodically replaced during 24 h and 
the dialysis was performed under slow stirring in a fume hood.
The BZL-loaded LNPs were prepared using the same method as 
described above. For that, 3 mg of carboxylated lignin were dissolved 
with 3 mL of THF containing 1 mg of BZL (mass ratio BZL:lignin of 1:3), 
and then introduced into a dialysis bag for the solvent exchange process, 
where the BZL-loaded LNPs were formed. The BZL loading into LNPs 
was determined by immersing the drug-loaded LNPs in ethanol for 
30 min under vigorous stirring to degrade the LNPs. After centrifugation 
at 16 100 rcf for 5 min, the supernatant was collected to determine 
the BZL concentration by using HPLC (Agilent 1100 series, Agilent 
Technologies, USA). The experimental conditions used for quantification 
of the loaded BZL are described in the literature,[24] and detailed in 
Table S5 (Supporting Information).
Dissolution Experiments: The dissolution experiments of the LNPs 
were done to evaluate their long-term stability at physiological 
conditions, after preparing LNPs from the different carboxylated lignin 
polymers. For that, 50, 200, and 500 µg mL−1 of LNPs were incubated 
in PBS pH 7.4, at 37 °C. Afterward, 100 µL of LNP suspension were 
withdrawn at determined time points (4, 6, 24, 48, and 72 h), and 
centrifuged at 16 100 rcf for 5 min. Finally, the absorbance of the 
supernatant at λ = 380 nm was measured by UV–vis spectroscopy using 
a Varioskan Flash plate reader (Thermo Fisher Scientific Inc., USA), and 







( ) = ×  (1)
To calculate the absorbance of the dissolved LNPs, the same 
concentration of LNPs was completely dissolved in ethanol, which 
corresponds to the maximum absorbance that the supernatant will have 
if dissolved at physiological conditions.
Characterization of LNPs: LNPs were characterized for their average 
particle size (Z-average), PDI, and average ζ-potential by DLS using a 
Malvern Zetasizer Nano ZS instrument (Malvern Instruments Ltd, UK). 
For that, the samples were diluted in MilliQ-water (50 µg mL−1). To 
characterize their morphology and confirm their size distribution, the 
LNPs were visualized by TEM (Jeol JEM-1400, Jeol Ltd., Tokyo, Japan), 
using an acceleration voltage of 80 kV. For the sample preparation, a 
droplet of LNPs’ suspension was mounted on a carbon-coated copper 
grid, blotted using a filter paper, and then air-dried before analysis. 
Additionally, the LNPs were also characterized by ATR−FTIR.
The stability of LNPs was also evaluated in Dulbecco’s modified 
Eagle’s medium (DMEM), supplemented with 10% (v/v) FBS. For 
that, samples were withdrawn at 5, 15, 30, 60, 90, and 120 min after 
incubation of 300 µg mL−1 of LNPs with the cell culturing medium 
at 37 °C, and posteriorly diluted in water to evaluate changes on the 
size and ζ-potential of the LNPs over time. All the experiments were 
performed in triplicates.
Conjugation of the Peptides to LNPs: The conjugation reaction between 
the COOH groups of LNPs and NH2 groups of DSS and iRGD 
peptides was performed in 10 × 10−3 m of MES buffer (pH 5.5), using 
EDC/NHS coupling chemistry. The molar amount of peptides used for 
the reaction was chosen taking in consideration the molecular weight of 
the peptides (Table S6, Supporting Information), and after optimization 
of the conjugation conditions. First, the carboxylic groups on the LNPs 
were activated by reacting 1 mg of LNPs in 400 µL of 100 × 10−3 m of 
MES buffer (pH 5.5), with 5 µL of EDC (40 × 10−3 m) and 4.6 mg of NHS 
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(100 × 10−3 m), and the mixture was stirred for 1 h at room temperature 
in the dark. Then, the mixture was centrifuged to remove excess EDC/
NHS, at 16 100 rcf for 5 min, and the LNPs were resuspended with 
500 µL of PBS pH 7.4 containing 250 × 10−6 m of the DSS and iRGD, 
for 4 h, to prepare LNPs-DSS and LNPs-iRGD, respectively. Afterward, 
the peptide-functionalized LNPs were centrifuged and washed twice with 
MilliQ water. The same conditions were used for the reaction between 
the BZL@LNPs and the DSS and iRGD to prepare BZL@LNPs-DSS and 
BZL@LNPs-iRGD, respectively.
Drug Release Studies: BZL was used to evaluate the in vitro release 
profiles of free BZL, BZL@LNPs, BZL@LNPs-iRGD, and BZL@LNPs-DSS, 
in two different buffers: HBSS–MES (pH 5.5) and HBSS–HEPES (pH 7.4), 
supplemented with 10% (v/v) of FBS after 4 h. For that, 30 µg of pure 
BZL and 100 µg of BZL-loaded LNPs were immersed in 10 mL of release 
media, and the samples were stirred at 150 rpm, at 37 °C. At scheduled 
time intervals (2, 5, 10, 15, 30, 60, 120, 240, 300, and 360 min), 200 µL 
of the release media were withdrawn and the same volume of fresh pre-
heated release media was added, keeping the releasing volume constant. 
Afterward, the samples were centrifuged at 16 100 rcf for 5 min and the 
supernatant was collected and analyzed in HPLC. The amount of BZL 
released was determined by measuring the BZL concentration using the 
HPLC method detailed in Table S5 (Supporting Information). The average 
values were obtained from three replicates.
Preparation of the 3D Tumor Spheroids: The 3D tumor spheroids were 
formed by the 3D bioprinting method. Initially, 1.5 mL of PC3-MM2, 
MDA-MB-231 and A549 cells were seeded in 6-well plates at a density of 
400 000 cells per well and allowed to attach overnight. Afterward, the cells 
were treated with 50 µL of NanoShuttle-PL (Nano3D Biosciences Inc., 
Germany) and incubated for 8–10 h for the magnetization of the cells. 
Then, the cells were washed twice with PBS buffer (pH 7.4) and seeded 
in ultralow attachment 96-well plates at a density of 5000 (PC3-MM2) or 
7000 (MDA-MB-231 and A549) cells per well, which was further placed 
atop the 96-well spheroid magnetic drive (Nano3D Biosciences Inc., 
Germany). The cells within the solution aggregated in the well plate, 
driven by the magnet, and the spheroids were cultured for 2 days.
Cytocompatibility Assessment: For the 2D model, PC3-MM2, MDA-MB-
231, and A549 cell lines were seeded in 96-well plates (PerkinElmer Inc., 
USA) at a density of 15 000 cells per well and allowed to attach overnight. 
Afterward, 100 µL of LNPs, LNPs-iRGD and LNPs-DSS suspensions in cell 
media at different concentrations (50, 100, 200, 300, 400, and 500 µg mL−1) 
were added to each well and the plates were incubated for 24 h at 37 °C. 
Incubations with cell media and 1% (v/v) Triton X-100 were used as a 
positive and negative controls, respectively. After that, the plates were 
equilibrated at room temperature for 30 min and the wells were washed 
once with 100 µL of HBSS–HEPES buffer. Then, 50 µL of CellTiter-Glo 
(Promega Corporation, USA) were added to 50 µL of HBSS–HEPES (pH 
7.4) in each well. The plates were stirred for 2 min on an orbital shaker 
and then stabilized for 30 min at room temperature, protected from the 
light. Finally, the luminescence was measured using a Varioskan Flash 
plate reader. The number of viable cells in culture was quantified based on 
the amount of ATP produced by metabolically active cells.[12,24]
After preparation of the 3D tumor spheroids, using PC3-MM2, 
MDA-MB-231, and A549 cells, as described above, the spheroids were 
gently transferred to 96-well plates (PerkinElmer Inc., USA) to evaluate 
the cytocompatibility of LNPs. Then, 50 µL of LNPs, LNPs-iRGD and 
LNPs-DSS suspensions at different concentrations were mixed with 
50 µL of NanoLuc luciferase and MT Cell Viability Substrate in complete 
cell culture medium, for 48 h at 37 °C. The final concentrations of NPs 
were 10, 25, 50, and 100 µg mL−1, and incubation with cell media was 
used as a positive control. The RealTime-Glo MT Cell Viability Assay is 
a nonlytic, homogeneous and bioluminescent method that allows to 
measure the cell viability in real time. The luminescence was measured 
using a Varioskan Flash plate reader, at the decided time point (48 h). 
The number of viable cells in culture was determined by measuring the 
reducing potential of cells, and thus metabolism. All the experiments 
were performed in triplicate.
Cell−LNP Interactions Using a 2D Cell Culture Model: For these 
experiments, the LNPs were loaded with a hydrophobic dye, DiA, in a mass 
ratio 100:1 (LNPs:DiA), and the conjugation reactions with the peptides 
were done, as described for the empty LNPs. Afterward, the interactions 
between the PC3-MM2, MDA-MB-231 and A549 cell lines and DiA-loaded 
LNPs, LNPs-iRGD, and LNPs-DSS were qualitatively and quantitatively 
evaluated by confocal microscopy and flow cytometry, respectively.
For confocal microscopy, 200 µL of 50 000 cells per well were seeded 
in Lab-Tek 8-chamber slides (Thermo Fisher Scientific, USA) and allowed 
to attach overnight. After removing the cell culture medium, 200 µL of 
100 µg mL−1 of LNP suspensions in PBS buffer (pH 7.4) were added to 
the cells and incubated for 3 h at 37 °C. Then, the cells were washed 
twice with PBS buffer, and the plasma membrane was stained by adding 
200 µL of CellMask Red (5 µg mL−1; Invitrogen, USA) and incubated for 
3 min at 37 °C. The excess of staining solution was washed once with 
fresh PBS buffer and the cells were fixed using 4% Paraformaldehyde 
(PFA) for 10 min at room temperature. Finally, the nuclei staining was 
done by adding 200 µL of DAPI-405 (2.8 µg mL−1; Thermo Scientific, 
USA) and incubated for 5 min at 37 °C. The localization of NPs was 
observed with a Leica SP5 inverted confocal microscope (Leica 
Microsystems, Germany), using a 63 × /1.2–0.6 oil immersion objective.
For flow cytometry analysis, 0.4 mL of cells were seeded in 24-well 
plates at a density of 100 000 cells per well and allowed to attach 
overnight. After removing the cell culture medium, the wells were 
washed once with PBS buffer (pH 7.4). Then, 0.3 mL of 100 µg mL−1 
of LNP suspensions were incubated with the cells for 3 h at 37 °C. 
After removing the LNPs and washing the cells once with PBS buffer 
to remove the nonadherent LNPs, the cells were harvested with Gibco 
Versene Solution for 5 min (0.48 × 10−3 m; Thermo Scientific, USA). 
Subsequently, the cells were washed once with PBS buffer and suspended 
with PBS−ethylenediamine tetraacetic acid (EDTA) (pH 7.4) for flow 
cytometer analysis. Flow cytometry was performed with an LSR II flow 
cytometer (BD Biosciences, USA), using a laser excitation wavelength of 
488 nm and an FACS Diva software. The data was analyzed using Flowjo 
VX software (Tree Star, Ashland, OR, USA) after collecting 20 000 events. 
All the experiments were performed in triplicate.
Cell−LNP Interactions Using a 3D Tumor Spheroids Model: The 
interaction of the LNPs with 3D tumor spheroids of PC3-MM2, MDA-
MB-231, and A549 cells was also qualitatively and quantitatively 
evaluated by confocal microscopy and flow cytometry, respectively. 
The 3D tumor spheroids were formed by the 3D bioprinting method, 
as described above. After removing the cell culture medium and 
washing the spheroids with PBS buffer, 100 µL of 100 µg mL−1 of 
LNPs’ suspension in PBS buffer (pH 7.4) were added to the cells and 
incubated at 37 °C for 3 h. Then, the cells were washed twice with PBS 
buffer to remove the nonadherent LNPs. For confocal microscopy, the 
spheroids were then fixed using 4% PFA for 24 h at 37 °C. Afterward, 
the spheroids were washed twice with PBS buffer, and the nuclei was 
posteriorly stained by adding 100 µL of DAPI-405 (2.8 µg mL−1) and 
incubated for 24 h at 37 °C. Finally, the cell spheroids were washed twice 
with PBS buffer and transferred to a Lab-Tek 8-chamber. The localization 
of NPs was observed with a Leica SP5 inverted confocal microscope 
(Leica Microsystems, Germany), equipped with a 20 × objective.
For flow cytometry, after incubation with the LNPs, the spheroids were 
harvested with trypsin-PBS-EDTA for 5 min, collected by centrifugation 
at 1600 rcf for 4 min, incubated with trypan blue (0.005% v/v) during 
4 min, washed twice with PBS−EDTA (pH 7.4), and finally suspended 
with PBS−EDTA. Flow cytometry was performed with an LSR II flow 
cytometer (BD Biosciences, USA), using a laser excitation wavelength of 
488 nm and an FACS Diva software. The data was analyzed by Flowjo VX 
software (Tree Star, Ashland, OR, USA) after collecting 5000 events. All 
the experiments were performed in triplicate.
In Vitro Anticancer Effect of the LNPs: The cell growth inhibition of 
pure BZL and BZL@LNPs, BZL@LNPs-iRGD, BZL@LNPs-DSS after 
incubation with PC3-MM2, MDA-MB-231, and A549 cells was evaluated 
using 2D and 3D cell culture models.
For the 2D model, PC3-MM2, MDA-MB-231, and A549 cells were 
seeded in 96-well-plated at a density of 10 000 cells per well and 
incubated overnight at 37 °C to allow the cells to attach. After that, 
100 µL of suspensions containing different concentrations of BZL-loaded 
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LNPs (5, 10, 25, 50 75, and 100 µg mL−1) and similar concentrations of 
pure BZL previously dissolved with 3% (v/v) ethanol (3.3, 8.2, 16.4, 32.9, 
and 65.7 × 10−6 m) in cell media were added to each well, and incubated 
for 6 and 24 h. Incubations with cell media and 1% (v/v) Triton X-100 
were used as a positive and negative controls, respectively. A specific 
control for pure BZL was also added with the same amount of ethanol 
used in the dilutions. After the incubation, the number of viable cells 
in culture was determined using the CellTiter-Glo luminescence cell 
viability assay kit (Promega Corporation, USA), and the luminescence 
was measured using a Varioskan Flash plate reader. All the experiments 
were performed at least in triplicate.
After transferring the 3D tumor spheroids (PC3-MM2, MDA-
MB-231 and A549 cells) to 96-well plates, 50 µL of BZL-loaded LNPs 
suspensions at different concentrations and similar concentrations of 
pure BZL previously dissolved with 3% (v/v) ethanol were added to each 
well, and mixed with 50 µL of NanoLuc luciferase and MT Cell Viability 
Substrate in complete cell culture medium, up to 48 h at 37 °C. The 
final concentration of NPs was 10, 25, 50, and 100 µg mL−1 and the free 
BZL was 6.57, 16.4, 32.9, and 65.7 × 10−6 m, and incubation with cell 
media was used as a positive control. Finally, the luminescence was 
measured, using a Varioskan Flash plate reader, at certain time points 
(6, 24, and 48 h). The number of viable cells in culture was determined 
by measuring the reducing potential of cells, and thus, the metabolism 
activity. All the experiments were performed in triplicate.
Afterward, the IC50, IC80, and IC90 values after incubation of BZL 
and BZL-loaded LNPs, LNPs-iRGD, and LNPs-DSS with PC3-MM2, 
MDA-MB-231, and A549 cells were obtained by means of a concentration 
response curve by nonlinear regression using OriginPro 2018.
Statistical Analysis: The measured values were expressed by mean ± 
standard deviation (s.d.). One-way analysis of variance (ANOVA) with 
Bonferroni posthoc test was used to evaluate the significant difference 
with probabilities set of *p < 0.05, **p < 0.01, and ***p < 0.001, using 
the GraphPad Prism (GraphPad software Inc., CA, USA).
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